Healthequity (HQY) Receives a Buy from Barrington

By Carrie Williams

Barrington analyst Alexander Paris reiterated a Buy rating on Healthequity (HQYResearch Report) today and set a price target of $75.00. The company’s shares closed last Monday at $62.89.

According to, Paris is currently ranked with no stars on a 0-5 star ranking scale, with an average return of -2.5% and a 41.4% success rate. Paris covers the Services sector, focusing on stocks such as American Public Education, Adtalem Global Education, and Franklin Covey Company.

Healthequity has an analyst consensus of Strong Buy, with a price target consensus of $75.67.

See today’s analyst top recommended stocks >>

Based on Healthequity’s latest earnings release for the quarter ending July 31, the company reported a quarterly net profit of $19.37 million. In comparison, last year the company had a net profit of $15.69 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

HealthEquity, Inc. provides range of solutions for managing health care accounts. The firm’s offers its solutions for employers, health planbs, brokers, consultants and financial advisors.